BRCA1 Carriers and Oral Contraceptives - Risk-benefit Calculation on Breast and Ovarian Cancer

被引：0
|
作者：
Schrijver, L. H. [1 ]
Rookus, M. A. [1 ]
Mooij, T. M. [1 ]
Pijpe, A. [1 ]
van Leeuwen, F. E. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Risk for breast and ovarian cancer modified by the use of oral contraceptives in BRCA1/2 mutation carriers
    Huber, D.
    Seitz, S.
    Kast, K.
    Emons, G.
    Ortmann, O.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E39 - E40
  • [2] Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kleeberg, UR
    STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (10) : 718 - 719
  • [3] Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Narod, SA
    Dubé, MP
    Klijn, J
    Lubinski, J
    Lynch, HT
    Ghadirian, P
    Provencher, D
    Heimdal, K
    Moller, P
    Robson, M
    Offit, K
    Isaacs, C
    Weber, B
    Friedman, E
    Gershoni-Baruch, R
    Rennert, G
    Pasini, B
    Wagner, T
    Daly, M
    Garber, JE
    Neuhausen, SL
    Ainsworth, P
    Olsson, H
    Evans, G
    Osborne, M
    Couch, F
    Foulkes, WD
    Warner, E
    Kim-Sing, C
    Olopade, O
    Tung, N
    Saal, HM
    Weitzel, J
    Merajver, S
    Gauthier-Villars, M
    Jernstrom, H
    Sun, P
    Brunet, JS
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (23): : 1773 - 1779
  • [4] Oral Contraceptives and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Figueiredo, Jane C.
    Haile, Robert W.
    Bernstein, Jonine L.
    CURRENT BREAST CANCER REPORTS, 2009, 1 (03) : 139 - 147
  • [5] Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Jane C. Figueiredo
    Robert W. Haile
    Jonine L. Bernstein
    Current Breast Cancer Reports, 2009, 1 (3) : 139 - 147
  • [6] Use of oral contraceptives and risk of breast cancer in BRCA1/2 mutation carriers
    Rookus, M.
    Brohet, R. M.
    Andrieu, N.
    Chang-Claude, J.
    Corbex, M.
    Loman, N.
    Easton, D. F.
    Goldgar, D. E.
    EJC SUPPLEMENTS, 2004, 2 (03): : 195 - 195
  • [7] Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Hopper, JL
    Baron, JA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) : 1010 - 1011
  • [8] Use of oral contraceptives and risk of breast cancer in BRCA1/2 mutation carriers.
    Rookus, MA
    Brohet, RM
    Andrieu, N
    Chang-Claude, J
    Corbex, M
    Loman, N
    Easton, DF
    Goldgar, DE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (11) : S42 - S42
  • [9] BRCA1/2 Mutation: oral Contraceptives and Risk of Ovarian Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (10) : 1082 - +
  • [10] Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation
    Modan, B
    Hartge, P
    Hirsh-Yechezkel, G
    Chetrit, A
    Lubin, F
    Beller, U
    Ben-Baruch, G
    Fishman, A
    Menczer, J
    Struewing, JP
    Tucker, MA
    Wacholder, S
    Ebbers, SM
    Friedman, E
    Piura, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (04): : 235 - 240
12345